Should Pharma Regain MES Leadership or Become the New IX Leaders?
Principal Analyst, Andrew Hughes, discusses the choice pharma companies need to make: regain their leadership in MES or become the new leaders in IX
Principal Analyst, Andrew Hughes, discusses the choice pharma companies need to make: regain their leadership in MES or become the new leaders in IX
LNS Research Principal Analyst Andrew Hughes revisits 7 Lives of MOM and examines MES as a strategy to jumpstart Industrial Transformation.
LNS Research Principal Analyst Andrew Hughes examines trends for the coming year with Factory of the Future initiatives that will help manufacturers...
LNS Research Principal Analyst Andrew Hughes reveals lessons learned from SAP's TechEd Virtual Conference and explores the SAP Busines Technology...
Dassault Systèmes (3DS) held its annual analysts’ meeting. Learn what three main economic sectors 3DS will focus on in the coming year.
The spread of COVID-19 is accelerating the closure of manufacturing plants. What can we do now and what can we change for recovery? Andrew Hughes...
The three pillars of IX—people, process and technology—are all vital to success, but today we discuss the pillar that is probably the most important...
LNS Research Principal Analyst, Andrew Hughes, answers 7 standout questions from his Factory of the Future: Optimizing the Plant for Industrial...
Research review of the 2019 Schneider Electric Innovation Summit in Barcelona.
Analysis of Siemens software and offerings for manufacturing companies and the Digital Twin.